Entirely New Flu Vaccine Needed Next Year, Says WHO
According to a report released by the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), the three most common types of influenza strains have changed in such a way that they are now showing signs of resistance to the Tamiflu and Relenza vaccines
According to a report released by the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), the three most common types of influenza strains have changed in such a way that they are now showing signs of resistance to the Tamiflu and Relenza vaccines.
For the first time in 20 years, the CDC is recommending a complete reformulation of the vaccine. In its FluView report for the week ending March 1, the CDC announced its recommendations for the formulation of the influenza vaccine for the 2008-2009 flu season. The recommendations are announced a year in advance because of the lengthy process by which the vaccines are produced. All three of the inactivated strains of the virus that were suggested for the 2008-2009 formulation are different from the current formulation.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
